These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 27467969

  • 1. Discharge BNP is a stronger predictor of 6-month mortality in acute heart failure compared with baseline BNP and admission-to-discharge percentage BNP reduction.
    Omar HR, Guglin M.
    Int J Cardiol; 2016 Oct 15; 221():1116-22. PubMed ID: 27467969
    [Abstract] [Full Text] [Related]

  • 2. Brain natriuretic peptide at discharge as a predictor of 6-month mortality in acute decompensated heart failure.
    Naffaa M, Makhoul BF, Tobia A, Jarous M, Kaplan M, Aronson D, Saliba W, Azzam ZS.
    Am J Emerg Med; 2014 Jan 15; 32(1):44-9. PubMed ID: 24210886
    [Abstract] [Full Text] [Related]

  • 3. Rise in BNP despite appropriate acute decompensated heart failure treatment : Patient characteristics and outcomes.
    Omar HR, Guglin M.
    Herz; 2017 Jun 15; 42(4):411-417. PubMed ID: 27624713
    [Abstract] [Full Text] [Related]

  • 4. Usefulness of combining admission brain natriuretic peptide (BNP) plus hospital discharge bioelectrical impedance vector analysis (BIVA) in predicting 90 days cardiovascular mortality in patients with acute heart failure.
    Santarelli S, Russo V, Lalle I, De Berardinis B, Navarin S, Magrini L, Piccoli A, Codognotto M, Castello LM, Avanzi GC, Villacorta H, Precht BLC, de Araújo Porto PB, Villacorta AS, Di Somma S, Great Network.
    Intern Emerg Med; 2017 Jun 15; 12(4):445-451. PubMed ID: 27987064
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
    Valle R, Aspromonte N, Giovinazzo P, Carbonieri E, Chiatto M, di Tano G, Feola M, Milli M, Fontebasso A, Barro S, Bardellotto S, Milani L.
    J Card Fail; 2008 Apr 15; 14(3):219-24. PubMed ID: 18381185
    [Abstract] [Full Text] [Related]

  • 8. Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims.
    Kociol RD, Horton JR, Fonarow GC, Reyes EM, Shaw LK, O'Connor CM, Felker GM, Hernandez AF.
    Circ Heart Fail; 2011 Sep 15; 4(5):628-36. PubMed ID: 21743005
    [Abstract] [Full Text] [Related]

  • 9. Longitudinal BNP follow-up as a marker of treatment response in acute heart failure: Relationship with objective markers of decongestion.
    Omar HR, Guglin M.
    Int J Cardiol; 2016 Oct 15; 221():167-70. PubMed ID: 27400316
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Extremely elevated BNP in acute heart failure: Patient characteristics and outcomes.
    Omar HR, Guglin M.
    Int J Cardiol; 2016 Sep 01; 218():120-125. PubMed ID: 27232923
    [Abstract] [Full Text] [Related]

  • 12. Acute systolic heart failure with normal admission BNP: clinical features and outcomes.
    Omar HR, Guglin M.
    Int J Cardiol; 2017 Apr 01; 232():324-329. PubMed ID: 28094130
    [Abstract] [Full Text] [Related]

  • 13. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW, Beede J, Isakson S, Villard-Saussine S, Fareh J, Clopton P, Fitzgerald RL, Maisel AS.
    J Am Coll Cardiol; 2008 May 13; 51(19):1874-82. PubMed ID: 18466803
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Predictive value for death and rehospitalization of 30-day postdischarge B-type natriuretic peptide (BNP) in elderly patients with heart failure. Sub-analysis of Italian RED Study.
    Di Somma S, Marino R, Zampini G, Magrini L, Ferri E, Shah K, Clopton P, Maisel AS.
    Clin Chem Lab Med; 2015 Feb 13; 53(3):507-13. PubMed ID: 25252752
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS).
    Cleland JGF, Teerlink JR, Davison BA, Shoaib A, Metra M, Senger S, Milo O, Cotter G, Bourge RC, Parker JD, Jondeau G, Krum H, O'Connor CM, Torre-Amione G, van Veldhuisen DJ, McMurray JJV, VERITAS Investigators.
    Eur J Heart Fail; 2017 Jun 13; 19(6):739-747. PubMed ID: 28296139
    [Abstract] [Full Text] [Related]

  • 20. Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure.
    Ueda T, Kawakami R, Sugawara Y, Okada S, Nishida T, Onoue K, Soeda T, Okayama S, Takeda Y, Watanabe M, Kawata H, Uemura S, Saito Y.
    J Am Heart Assoc; 2014 Nov 04; 3(6):e001174. PubMed ID: 25370599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.